| Product Code: ETC10689314 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Oncology Companion Diagnostics Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Poland Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Poland Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Poland Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Poland Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Poland Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Poland Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Poland |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in companion diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 High costs associated with companion diagnostic tests |
4.3.3 Limited reimbursement policies for companion diagnostics in Poland |
5 Poland Oncology Companion Diagnostics Market Trends |
6 Poland Oncology Companion Diagnostics Market, By Types |
6.1 Poland Oncology Companion Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Poland Oncology Companion Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Poland Oncology Companion Diagnostics Market Revenues & Volume, By NGS-Based, 2021 - 2031F |
6.1.5 Poland Oncology Companion Diagnostics Market Revenues & Volume, By IHC-Based, 2021 - 2031F |
6.1.6 Poland Oncology Companion Diagnostics Market Revenues & Volume, By FISH-Based, 2021 - 2031F |
6.2 Poland Oncology Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 Poland Oncology Companion Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.4 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.3.5 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Poland Oncology Companion Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Poland Oncology Companion Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
7 Poland Oncology Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Poland Oncology Companion Diagnostics Market Export to Major Countries |
7.2 Poland Oncology Companion Diagnostics Market Imports from Major Countries |
8 Poland Oncology Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics in oncology treatments |
8.2 Number of partnerships and collaborations in the oncology companion diagnostics market |
8.3 Rate of development and commercialization of new companion diagnostic tests |
8.4 Patient outcomes and survival rates with the use of companion diagnostics |
9 Poland Oncology Companion Diagnostics Market - Opportunity Assessment |
9.1 Poland Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Poland Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Poland Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Poland Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10 Poland Oncology Companion Diagnostics Market - Competitive Landscape |
10.1 Poland Oncology Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Poland Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here